Aujla, A., Aujla, R., & Liu, D. (2019). Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Biomark Res.
Citação norma ChicagoAujla, Amandeep, Ravijot Aujla, and Delong Liu. "Inotuzumab Ozogamicin in Clinical Development for Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma." Biomark Res 2019.
MLA引文Aujla, Amandeep, Ravijot Aujla, and Delong Liu. "Inotuzumab Ozogamicin in Clinical Development for Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma." Biomark Res 2019.
警告：這些引文格式不一定是100％准確.